Merit Medical Systems, Inc. (MMSI) Shares Bought by Wells Fargo & Company MN

Wells Fargo & Company MN raised its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 189.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 324,487 shares of the medical instruments supplier’s stock after purchasing an additional 212,304 shares during the quarter. Wells Fargo & Company MN owned approximately 0.65% of Merit Medical Systems worth $13,742,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the business. Aperio Group LLC grew its position in shares of Merit Medical Systems by 3.9% in the 2nd quarter. Aperio Group LLC now owns 10,467 shares of the medical instruments supplier’s stock worth $399,000 after buying an additional 391 shares during the period. Suntrust Banks Inc. grew its position in shares of Merit Medical Systems by 5.6% in the 2nd quarter. Suntrust Banks Inc. now owns 7,847 shares of the medical instruments supplier’s stock worth $299,000 after buying an additional 414 shares during the period. Cornerstone Capital Management Holdings LLC. grew its position in shares of Merit Medical Systems by 7.2% in the 2nd quarter. Cornerstone Capital Management Holdings LLC. now owns 7,400 shares of the medical instruments supplier’s stock worth $282,000 after buying an additional 500 shares during the period. Symphony Asset Management LLC grew its position in shares of Merit Medical Systems by 4.1% in the 2nd quarter. Symphony Asset Management LLC now owns 17,282 shares of the medical instruments supplier’s stock worth $659,000 after buying an additional 680 shares during the period. Finally, Ameritas Investment Partners Inc. grew its position in shares of Merit Medical Systems by 20.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after buying an additional 738 shares during the period. 90.65% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Kent W. Stanger sold 9,082 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $44.90, for a total value of $407,781.80. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 5.00% of the stock is owned by corporate insiders.

Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at $43.00 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. The stock has a market cap of $2,140.00, a PE ratio of 71.67, a price-to-earnings-growth ratio of 2.94 and a beta of 1.23. Merit Medical Systems, Inc. has a one year low of $24.23 and a one year high of $45.90.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The firm had revenue of $179.30 million for the quarter, compared to analysts’ expectations of $181.28 million. During the same quarter in the prior year, the business earned $0.26 EPS. The business’s quarterly revenue was up 14.2% on a year-over-year basis. equities research analysts forecast that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current fiscal year.

MMSI has been the topic of a number of analyst reports. ValuEngine cut shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. BidaskClub cut shares of Merit Medical Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Canaccord Genuity reiterated a “buy” rating and issued a $45.00 price target on shares of Merit Medical Systems in a research note on Sunday, October 8th. Raymond James Financial reiterated an “outperform” rating and issued a $44.00 price target on shares of Merit Medical Systems in a research note on Monday, August 28th. Finally, UBS Group cut shares of Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research note on Monday, August 28th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $43.77.

ILLEGAL ACTIVITY NOTICE: “Merit Medical Systems, Inc. (MMSI) Shares Bought by Wells Fargo & Company MN” was originally reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://www.com-unik.info/2017/12/24/merit-medical-systems-inc-mmsi-shares-bought-by-wells-fargo-company-mn.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

What are top analysts saying about Merit Medical Systems? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merit Medical Systems and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit